Insights

Innovative Technology Leadership LUMICKS specializes in cutting-edge single-molecule and cell avidity analysis instruments based on Nobel Prize-winning technologies like optical tweezers and super-resolution microscopy. Their advanced tools provide unique capabilities to analyze complex biological interactions in real-time, offering significant value to research institutions and biotech firms seeking high-precision measurement solutions.

Recent Funding Strength The company secured €20 million (approximately $21.9 million) in venture debt from the European Investment Bank in October 2024, indicating strong financial backing and growth potential. This funding can support sales efforts by enabling expansion into new markets and enhancing product development efforts.

Increasing Market Presence Recent product launches, including the introduction of the C-Trap platform and branding updates, demonstrate active product innovation and market positioning. These developments present opportunities to engage research labs and biotech companies interested in the latest tools for molecular and cellular analysis.

Focus on Life Science Applications LUMICKS' emphasis on health-related research, such as improving CAR T cell therapies for cancer, positions it well within the biotech and pharmaceutical sectors. Partnering with organizations involved in immunotherapy and personalized medicine can open avenues for tailored sales strategies.

Strategic Leadership Appointments The appointment of key executives like CEO Hugo de Wit and CFO Andre Nel highlights a focus on strategic growth and operational excellence. Leveraging leadership changes can facilitate targeted outreach to prospects who value a strong management team and innovative company vision.

LUMICKS Tech Stack

LUMICKS uses 8 technology products and services including Figma, Google Maps, Bootstrap, and more. Explore LUMICKS's tech stack below.

  • Figma
    Design
  • Google Maps
    Maps
  • Bootstrap
    UI Frameworks
  • LabVIEW
    Visualisation Software
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts
  • Contact Form 7
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

LUMICKS's Email Address Formats

LUMICKS uses at least 1 format(s):
LUMICKS Email FormatsExamplePercentage
F.Last@lumicks.comJ.Doe@lumicks.com
98%
First.Last@lumicks.comJohn.Doe@lumicks.com
1%
FirstMiddleLas@lumicks.comJohnMichaelDoe@lumicks.com
1%

Frequently Asked Questions

What is LUMICKS's official website and social media links?

Minus sign iconPlus sign icon
LUMICKS's official website is lumicks.com and has social profiles on LinkedInCrunchbase.

What is LUMICKS's SIC code NAICS code?

Minus sign iconPlus sign icon
LUMICKS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LUMICKS have currently?

Minus sign iconPlus sign icon
As of December 2025, LUMICKS has approximately 201 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: H. D.Cfo: E. V. -. V. D.Coo: G. O. E.. Explore LUMICKS's employee directory with LeadIQ.

What industry does LUMICKS belong to?

Minus sign iconPlus sign icon
LUMICKS operates in the Biotechnology Research industry.

What technology does LUMICKS use?

Minus sign iconPlus sign icon
LUMICKS's tech stack includes FigmaGoogle MapsBootstrapLabVIEWGoogle AnalyticsAdobe FontsContact Form 7Nginx.

What is LUMICKS's email format?

Minus sign iconPlus sign icon
LUMICKS's email format typically follows the pattern of F.Last@lumicks.com. Find more LUMICKS email formats with LeadIQ.

How much funding has LUMICKS raised to date?

Minus sign iconPlus sign icon
As of December 2025, LUMICKS has raised $22M in funding. The last funding round occurred on Oct 10, 2024 for $22M.

When was LUMICKS founded?

Minus sign iconPlus sign icon
LUMICKS was founded in 2014.

LUMICKS

Biotechnology ResearchNorth Holland, Netherlands201-500 Employees

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. 

Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail.

Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $22M

    LUMICKS has raised a total of $22M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2024 in the amount of $22M.

  • $1M

    LUMICKS's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $22M

    LUMICKS has raised a total of $22M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2024 in the amount of $22M.

  • $1M

    LUMICKS's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.